​

Iovance Biotherapeutics (IOVA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Iovance Biotherapeutics Revenue Highlights

Latest Revenue (Y)

$164.07M

Latest Revenue (Q)

$67.45M

Main Geography (Y)

UNITED STATES

Iovance Biotherapeutics Revenue by Period

Iovance Biotherapeutics Revenue by Year

DateRevenueChange
2024-12-31$164.07M13698.99%
2023-12-31$1.19M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31--

Iovance Biotherapeutics generated $164.07M in revenue during NA 2024, up 13698.99% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Iovance Biotherapeutics Revenue by Quarter

DateRevenueChange
2025-09-30$67.45M12.52%
2025-06-30$59.95M21.55%
2025-03-31$49.32M-33.07%
2024-12-31$73.69M25.86%
2024-09-30$58.55M88.24%
2024-06-30$31.11M4250.49%
2024-03-31$715.00K48.34%
2023-12-31$482.00K2.77%
2023-09-30$469.00K97.06%
2023-06-30$238.00K100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31--

Iovance Biotherapeutics generated $67.45M in revenue during Q3 2025, up 12.52% compared to the previous quarter, and up 216.86% compared to the same period a year ago.

Iovance Biotherapeutics Revenue Breakdown

Iovance Biotherapeutics Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceSep 23Jun 23
Product$500.00K$200.00K

Iovance Biotherapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: Product (100.00%).

Iovance Biotherapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 24Dec 23
Non-US$3.03M$1.20M
UNITED STATES$161.04M-

Iovance Biotherapeutics's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (98.16%), and Non-US (1.84%).

Quarterly Revenue by Country

CountrySep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23
Non-US$1.05M$1.35M$804.00K$1.59M$740.00K$700.00K$500.00K$500.00K$200.00K
UNITED STATES$66.40M$58.60M$48.52M$103.23M$57.81M----

Iovance Biotherapeutics's latest quarterly revenue breakdown by geography, as of Sep 25: UNITED STATES (98.44%), and Non-US (1.56%).

Iovance Biotherapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
DNAGinkgo Bioworks$227.04M$49.60M
IOVAIovance Biotherapeutics$164.07M$67.45M
CTMXCytomX Therapeutics$138.10M$18.66M
VIRVir Bio$74.20M$240.00K
MGTXMeiraGTx$33.28M$3.69M
MLTXMoonLake Immunotherapeutics--
REPLReplimune Group--
ATXSAstria Therapeutics-$706.00K
MBXMBX Biosciences--
ERASErasca--
AVBPArriVent BioPharma--

IOVA Revenue FAQ

What is Iovance Biotherapeutics’s yearly revenue?

Iovance Biotherapeutics's yearly revenue for 2024 was $164.07M, representing an increase of 13698.99% compared to 2023. The company's yearly revenue for 2023 was $1.19M, representing an increase of 100.00% compared to 2022. IOVA's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Iovance Biotherapeutics’s quarterly revenue?

Iovance Biotherapeutics's quarterly revenue for Q3 2025 was $67.46M, a 12.52% increase from the previous quarter (Q2 2025), and a 15.20% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $59.95M, a 21.55% increase from the previous quarter (Q1 2025), and a 92.73% increase year-over-year (Q2 2024). IOVA's quarterly revenue for Q1 2025 was $49.32M, a -33.07% decrease from the previous quarter (Q4 2024), and a 6798.46% increase year-over-year (Q1 2024).

What is Iovance Biotherapeutics’s revenue growth rate?

Iovance Biotherapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.